Nymox Pharma (NYMX) Announces Phase 3 Long-Term Fexapotide Repeat Injection BPH Trial Results
Go back to Nymox Pharma (NYMX) Announces Phase 3 Long-Term Fexapotide Repeat Injection BPH Trial ResultsNymox Pharmaceutical Corp (NASDAQ: NYMX) | Delayed: 0.20 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.20 | 52 Week High | $5.79 | |||
Open | $0.20 | 52 Week Low | $1.62 | |||
Day High | $0.20 | P/E | N/A | |||
Day Low | $0.20 | EPS | $-0.18 | |||
Volume | 629,050 |